
Shashank Nagendra
@hankshas
Interventional Stroke Neurologist
@JJHospitalMumbai @DCNSNeuro
ID: 85785061
28-10-2009 10:10:02
1,1K Tweet
284 Followers
334 Following



In patients w/ cardiovascular disease & overweight or obesity but no diabetes, semaglutide was superior to placebo in lowering the risk of major adverse cardiovascular events at a mean follow-up of 39.8 mos. Full SELECT trial results: nej.md/465pj91 #AHA23 AHA Science










New from JNIS: bit.ly/48Ko4xe Canadian Stroke Consortium Canadian Interventional Neuro Group 🇨🇦CULVO study shows: 1) 1 in 5 decisions for late-window EVT will change with perfusion imaging vs without 2) Reliability of EVT decisions with or without perfusion imaging is not significantly different



Great learning case. A recent ear of the Lynx caught by Shashank Nagendra in an advanced case.





